Doctors in Denial: Why Big Pharma and the Canadian medical profession are too close for comfort

[Joel Lexchin] ✓ Doctors in Denial: Why Big Pharma and the Canadian medical profession are too close for comfort ↠ Read Online eBook or Kindle ePUB. Doctors in Denial: Why Big Pharma and the Canadian medical profession are too close for comfort ]

Doctors in Denial: Why Big Pharma and the Canadian medical profession are too close for comfort

Author :
Rating : 4.77 (585 Votes)
Asin : 1459412443
Format Type : paperback
Number of Pages : 344 Pages
Publish Date : 2015-04-26
Language : English

DESCRIPTION:

Big Pharma plays a role in every aspect of doctors' work. But almost all doctors deny the influence and control the drug companies exert. These giant, wealthy multinationals influence how medical students are trained and receive information, how research is done in hospitals and universities, what is published in leading medical journals, what drugs are approved, and what patients expect when they go into their doctors' offices. In this book Dr. Lexchin urges the medical profession to make the changes needed to give priority to protecting and promoting patients' health and benefitting society, rather than enab

He has been an advocate for change in pharmaceutical policy for thirty-five years, has appearedbefore numerous parliamentary committees, and has authored or co-authored over 150 articles about all aspects of how medicines are developed and used. His most recent book Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State was published in early 2016.. He received his MD from

He received his MD from the University of Toronto in 1977 and has spent overthirty years working as an emergency physician in Hamilton and Toronto. About the AuthorJoel Lexchin is an internationally-recognized expert in pharmaceutical policy. He has been an advocate for change in pharmaceutical policy for thirty-five years, has appearedbefore numerous parliamentary committees, and has authored or co-authored over 150 articles about all aspects of how medicines are developed and used. He is a Professor Emeritus in the School of Health Policy and Management at YorkUniversity where he taught health policy from 2001 to 2016. His most recent book Private Profits versus Public Policy: The Pharmaceutical I